Impact of public health insurance coverage of novel anticancer medication on medical expenditure and patient affordability in a provincial medical centre of China: a propensity score-matching analysis with the quasi-experimental design
Hong Li,
Jing Sun,
Ji Huang,
Kai Xu,
Yifan Diao,
Mengbo Lin,
Xiongwei Wu,
Mingshuang Li
Affiliations
Hong Li
Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China
Jing Sun
School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Ji Huang
Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China
Kai Xu
Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China
Yifan Diao
School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Mengbo Lin
Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China
Xiongwei Wu
Affiliated Clinical Medical Institute of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian, China
Mingshuang Li
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
